stockrowMettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.
- Revenue
- +6.27%
- EPS
- +16.2%
- Free cash flow
- +33.0%
- Total debt
- −8.42%
Quarter to September 2026, against a year earlier
Follow MTD
Alert me
Mettler-Toledo International, Inc. (MTD) EPS (diluted)
Mettler-Toledo International, Inc.'s EPS (diluted) for fiscal 2025 was $42.05, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $46.15. Over the past ten years it has ranged from $12.48 (fiscal 2015) to $42.05 (fiscal 2025) — the current reading is the highest in ten years. Mettler-Toledo International, Inc. ranks 1st of 49 Diagnostics & Research companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $42.05 | 3.88% |
| FY2024 | $40.48 | 12.76% |
| FY2023 | $35.90 | (6.53%) |
| FY2022 | $38.41 | 17.18% |
| FY2021 | $32.78 | 31.59% |
| FY2020 | $24.91 | 10.86% |
| FY2019 | $22.47 | 13.03% |
| FY2018 | $19.88 | 39.61% |
| FY2017 | $14.24 | 0.14% |
| FY2016 | $14.22 | 13.94% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $12.29 | 6.41% |
| Jun 2026 | $11.55 | 38.66% |
| Mar 2026 | $8.33 | (40.41%) |
| Dec 2025 | $13.98 | 32.26% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| MTD Mettler-Toledo International, Inc. | $44.43 |
| IDXX IDEXX Laboratories, Inc. compare | $14.83 |
| LH Labcorp Holdings Inc. compare | $12.19 |
| DGX Quest Diagnostics Incorporated compare | $10.04 |
| IQV IQVIA Holdings Inc. compare | $8.24 |
| ILMN Illumina, Inc. compare | $5.81 |
| A Agilent Technologies, Inc. compare | $5.08 |
| WAT Waters Corporation compare | $2.33 |
| GH Guardant Health, Inc. compare | −$3.68 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on MTD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement